Pak Cheong Sin
Director/Board Member at YESASIA HOLDINGS LIMITED
Net worth: - $ as of 2024-06-29
Pak Cheong Sin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| YESASIA HOLDINGS LIMITED | Director/Board Member | 2021-06-18 | - |
| Independent Dir/Board Member | 2021-06-18 | - | |
| Belief Biomed Ltd. | Corporate Officer/Principal | 2022-03-31 | - |
Career history of Pak Cheong Sin
Former positions of Pak Cheong Sin
| Companies | Position | Start | End |
|---|---|---|---|
HiFiBiO Inc.
 HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Director of Finance/CFO | 2020-10-31 | 2021-07-31 |
Orient Securities Investment Banking Co., Ltd.
 Orient Securities Investment Banking Co., Ltd. Investment Banks/BrokersFinance Part of Orient Securities Co., Ltd., Orient Securities Investment Banking Co., Ltd. is a Chinese company that provides securities brokerage services. The company is based in Shanghai, China. The company was founded in 2012. Ji Ma has been the CEO of the company since 2012. Orient Securities Investment Banking Co. was acquired by Orient Securities Co., Ltd. from Citigroup Global Markets Asia Ltd. on April 22, 2020 for $69.43 million. | Corporate Officer/Principal | 2013-02-28 | 2020-10-31 |
Citigroup Global Markets Asia Ltd.
 Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Corporate Officer/Principal | 2009-08-31 | 2013-01-31 |
| UBS GROUP AG | Corporate Officer/Principal | 2006-05-31 | 2008-11-30 |
| DEUTSCHE BANK AG | Corporate Officer/Principal | 2003-07-31 | 2006-05-31 |
Training of Pak Cheong Sin
| Dartmouth College | Undergraduate Degree |
Statistics
International
| Hong Kong | 4 |
| United States | 3 |
| Germany | 2 |
Operational
| Corporate Officer/Principal | 5 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Finance | 5 |
| Consumer Services | 2 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| DEUTSCHE BANK AG | Finance |
| UBS GROUP AG | Finance |
| YESASIA HOLDINGS LIMITED | Technology Services |
| Private companies | 4 |
|---|---|
Citigroup Global Markets Asia Ltd.
Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Finance |
Orient Securities Investment Banking Co., Ltd.
Orient Securities Investment Banking Co., Ltd. Investment Banks/BrokersFinance Part of Orient Securities Co., Ltd., Orient Securities Investment Banking Co., Ltd. is a Chinese company that provides securities brokerage services. The company is based in Shanghai, China. The company was founded in 2012. Ji Ma has been the CEO of the company since 2012. Orient Securities Investment Banking Co. was acquired by Orient Securities Co., Ltd. from Citigroup Global Markets Asia Ltd. on April 22, 2020 for $69.43 million. | Finance |
HiFiBiO Inc.
HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Health Technology |
| Belief Biomed Ltd. |
- Stock Market
- Insiders
- Pak Cheong Sin
- Experience
